The Liver Meeting brings together clinicians, associates, and scientists from around the world to exchange information on the latest research, discuss new developments in liver treatment and transplantation, and network with leading experts in the field of hepatology.
Our Attendees Include:
- Adult and pediatric hepatology experts.
- Clinical, basic, and translational researchers.
- Specialists who diagnose and treat liver disease, including gastroenterologists, surgeons, clinical pathologists, anesthesiologists, and radiologists.
- Primary care physicians.
- Nurse practitioners, registered nurses, physician assistants, pharmacists, and other allied health professionals in hepatology and the disciplines listed above.
- Trainees, and students in the disciplines listed above.
- Patient advocates and patients.
Topics :
– 2021 Academic Debates
– AASLD & AASLD Foundation Awards & Honors Ceremony
– AASLD Distinguished Award
– AASLD_ALEH Joint Symposium
– AASLD_ASGE Endoscopy Course Live Q&A Session
– AASLD_ILTS Transplant Course Live Q&A Session
– Alcohol, Cancer, Fibrosis Cirrhosis Portal Hypertension
– Alcohol, NASH and NAFLD
– Alcohol-associated Liver Disease
– Associates, Health Outcomes, Fibrosis Cirrhosis Portal Hypertension, TransplantLiver Failure
– Basic Translational Science, Microbiome Genomics Personalized Medicine
– Basic Science Debrief
– Cancer, Transplant Liver Failure, NASH and NAFLD
– Career Development Workshop
– Cholestatic and Autoimmune Liver Diseases
– Cirrhosis Improving Quality through Patient Empowerment
– Clinical Hepatology Debrief
– Clinical Research Workshop – Part I
– Clinical Research Workshop – Part II
– COVID-19 and the Liver Symposium
– Diversity Workshop
– Emerging Trends Symposium
– Fibrosis Cirrhosis Portal Hypertension, TransplantLiver Failure, Pediatric
– Grit, Grace, Gratitude, and Resilience What You Wish Your Doctors Knew About You
– HBV Cure How Close Are We
– HBV Global Symposium
– Health Outcomes, Fibrosis Cirrhosis Portal Hypertension, TransplantLiver Failure, NASH and NAFLD
– Health Outcomes, Public Health
– Health Outcomes, Training and Career Development, Public Health
– Hepatitis B
– Hepatitis C
– Hepatitis Debrief
– Hepatology Associates
– Hepatotoxicity SIG
– Hyman J. Zimmerman Hepatotoxicity State-of-the-Art Lecture
– Leon Schiff State-of-the-Art Lecture
– Liver Cancer
– Liver Cell Biology
– Liver Fibrosis
– Liver Transplantation and Surgery SIG
– Making an Impact Where You Are Patient Voices as a Vehicle for Change
– Microbiome Genomics Personalized Medicine
– NAFLD Debrief
– Nonalcoholic Fatty Liver Disease
– Nutrition 101 for Patients with Chronic Liver Disease
– Panel Discussion Saving More Lives Forward from “A Burden of Genius”
– Parallel 1 Advances with Approved HBV Therapies
– Parallel 2 Health Services and Public Health
– Parallel 3 Metabolic and Genetic Disease Hemochromatosis, Wilsons Disease, Alpha-1 Antitrypsin Deficiency
– Parallel 4 COVID-19 Clinical
– Parallel 5 Pediatric Hepatology Metabolic and Genetic Diseases
– Parallel 6- Experimental and Translational Portal Hypertension and ACLF – The World’s Premier Event in Hepatology
– Parallel 7 Immunosuppression, Outcomes, Complications
– Parallel 8 HBV Cascade of Care, Natural History and Diagnostics
– Parallel 9 COVID-19 Translational and Clinical
– Parallel 10 Diagnostics and Biomarkers of NAFLD
– Parallel 11 Healthcare Quality and Access in Hepatology
– Parallel 12 Donor and Allocation Issues, Living and Split Donor Liver Transplantation
– Parallel 13 Novel HBV Therapies and Approaches
– Parallel 14 Hepatitis C Oral Session
– Parallel 15 Biomarkers and Therapeutics in Autoimmune and Cholestatic Diseases
– Parallel 16 Experimental and Translational Advances in Alcohol-Associated Liver Disease
– Parallel 17 NAFLD and NASH Predicting Outcomes and Response to Interventions
– Parallel 18 Mechanisms of Cholestatic Liver Injury
– Parallel 19 Clinical Advances in Alcohol-Associated Liver Disease
– Parallel 20 Hepatobiliary Neoplasia Clinical Oral Session
– Parallel 21 NAFLD and NASH Clinical Trials of Novel Therapeutics
– Parallel 22 Portal Hypertension Risk Stratification and Treatment for Varices
– Parallel 23 Cell and Molecular Biology
– Parallel 24 Hepatobiliary Neoplasia Experimental Translational Oral Session
– Parallel 25 Portal Hypertension Clinical
– Parallel 26 Liver Fibrogenesis and Non-Parenchymal Cell Biology
– Parallel 27 Diversity, Equity, and Inclusion in Liver Disease Care
– Parallel 28 Gut Liver Axis and Microbiome
– Parallel 29 NAFLD and NASH Management and Outcomes in the Clinic
– Parallel 30- Genomics and Precision Medicine – The World’s Premier Event in Hepatology
– Parallel 31 Clinical Translational Research in Pediatric Hepatology
– Parallel 32 Clinical Acute on Chronic Liver Failure
– Parallel 34 Basic Science Research in Pediatric Hepatology
– Parallel 35 Viral Hepatitis Oral Session (Non-HBV, Non-HCV)
– Parallel 36 Hepatotoxicity
– Patient Annual Forum and Meet & Greet Networking
– Patient Debrief
– Patient Keynote How Physician-Patient Partnerships Can Improve Liver Disease Care & Research
– Pediatric Liver Disorders and Acute on Chronic Liver Failure SIG Program – Part I Management of Acute-on-Chronic Liver Failure in Adults and Children
– Pediatric Liver Disorders and Acute on Chronic Liver Failure SIG Program – Part II Management of Acute-on-Chronic Liver Failure in Adults and Children
– Pediatric, Cholestatic and Autoimmune Liver Disease
– Portal Hypertension Clinical and Experimental
– Postgraduate Course – Part I
– Postgraduate Course – Part II
– Postgraduate Course – Part III
– Postgraduate Course Live Q&A Session
– Practice Guidelines Debrief for Patients
– Practice Guidelines Workshop
– Presidential Plenary Basic and Translational
– Presidential Plenary Clinical and Translational
– Presidential Plenary Liver Transplant
– Presidential Welcome and President’s Choice Lecture
– Public Health Health Care Delivery
– The Liver Meeting Closing Remarks
– Transplant Surgery Workshop Part I (Increased-risk Organs)
– Transplant Surgery Workshop Part II (Living Donor, Split Liver)
– TransplantLiver Failure, Microbiome Genomics Personalized Medicine
– Viral Hepatitis Elimination Session
– Women’s Health Program
Release Date : November 13-16 2021
Reviews
There are no reviews yet.